We are live on ! Find out more
CCM

Channing Capital Management Portfolio holdings

AUM $4.34B
1-Year Est. Return 37.08%
This Fund
S&P 500
This Quarter Est. Return
+0.1%
1 Year Est. Return
+37.08%
3 Year Est. Return
+81.15%
5 Year Est. Return
+102.23%
10 Year Est. Return
+435.32%
AUM
$3.75B
AUM Growth
-$160M
Cap. Flow
-$136M
Cap. Flow %
-3.63%
Top 10 Hldgs %
26.15%
Holding
123
New
15
Increased
33
Reduced
59
Closed
16

Top Sells

Rank Stock Value
1
XPO icon
XPO
XPO
+$94.1M
2
ENOV icon
Enovis
ENOV
+$54.3M
3
EVR icon
Evercore
EVR
+$39.2M
4
HRI icon
Herc Holdings
HRI
+$24.9M
5
SIGI icon
Selective Insurance
SIGI
+$20M

Sector Composition

Rank Sector Weight
1 Financials 26%
2 Industrials 22.25%
3 Technology 11.34%
4 Consumer Discretionary 10.86%
5 Real Estate 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXTA icon
51
Axalta
AXTA
$8.17B
$11.9M 0.32%
348,111
-4,549
-1% -$171K
ITT icon
52
ITT
ITT
$19.1B
$11.7M 0.31%
82,024
-1,041
-1% -$156K
THG icon
53
Hanover Insurance
THG
$7.98B
$11.6M 0.31%
75,255
-976
-1% -$151K
TER icon
54
Teradyne
TER
$59.3B
$11.3M 0.3%
89,737
+8,291
+10% +$981K
CR icon
55
Crane Co
CR
$12.7B
$11.1M 0.3%
73,173
-931
-1% -$154K
CG icon
56
Carlyle Group
CG
$17.2B
$10.9M 0.29%
215,970
-2,732
-1% -$138K
ARMK icon
57
Aramark
ARMK
$14.7B
$10.9M 0.29%
291,926
-3,688
-1% -$143K
IVZ icon
58
Invesco
IVZ
$13.9B
$10.9M 0.29%
622,217
-8,263
-1% -$147K
ABBV icon
59
AbbVie
ABBV
$435B
$10.8M 0.29%
60,798
+5,397
+10% +$992K
CSL icon
60
Carlisle Companies
CSL
$15.4B
$10.8M 0.29%
29,248
+3,062
+12% +$1.33M
RRX icon
61
Regal Rexnord
RRX
$11.9B
$10.6M 0.28%
68,422
+14,641
+27% +$2.47M
C icon
62
Citigroup
C
$226B
$10.6M 0.28%
+150,629
New +$10.2M
TKR icon
63
Timken Company
TKR
$9.03B
$10.6M 0.28%
148,112
+12,812
+9% +$1.01M
PNW icon
64
Pinnacle West Capital
PNW
$12.2B
$10.4M 0.28%
123,081
+23,605
+24% +$2.1M
CRM icon
65
Salesforce
CRM
$158B
$10.3M 0.27%
30,834
-3,435
-10% -$1.1M
WFC icon
66
Wells Fargo
WFC
$264B
$10.2M 0.27%
145,663
-7,922
-5% -$541K
TXN icon
67
Texas Instruments
TXN
$261B
$10.1M 0.27%
+53,836
New +$10.8M
PM icon
68
Philip Morris
PM
$295B
$9.63M 0.26%
80,038
-4,089
-5% -$516K
WSC icon
69
WillScot Mobile Mini Holdings
WSC
$4.41B
$9.53M 0.25%
284,996
-3,599
-1% -$132K
EW icon
70
Edwards Lifesciences
EW
$51.7B
$9.28M 0.25%
+125,371
New +$8.77M
CRL icon
71
Charles River Laboratories
CRL
$12.8B
$9.22M 0.25%
49,931
-676
-1% -$130K
GILD icon
72
Gilead Sciences
GILD
$165B
$9.11M 0.24%
98,658
-6,347
-6% -$571K
ELV icon
73
Elevance Health
ELV
$85.5B
$9.08M 0.24%
+24,619
New +$10.3M
BA icon
74
Boeing
BA
$185B
$9.05M 0.24%
51,106
+2,216
+5% +$348K
PR
75
Permian Resources
PR
$16.9B
$8.92M 0.24%
620,138
+459,516
+286% +$6.66M

Similar funds

Channing Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Channing Capital Management held 123 positions worth $3.75B, down 4.1% from $3.91B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Channing Capital Management withdrew a net $136M in Q4 2024, closing 16 positions and reducing 59 holdings. Its most notable exit was Enovis, an estimated $54.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 24% a quarter earlier, followed by Industrials and Technology.

Against the trend, Channing Capital Management opened a new position in Cushman & Wakefield Ltd worth $61.7M.

  • Channing Capital Management's largest Q4 2024 buy was Cushman & Wakefield Ltd: 4,719,558 shares worth $61.7M.
  • Channing Capital Management added most to PVH in Q4 2024, an estimated $32.5M increase.
  • Channing Capital Management's biggest Q4 2024 reduction was XPO, cutting an estimated $94.1M.
  • Channing Capital Management fully exited Enovis in Q4 2024, selling an estimated $54.3M.
  • Channing Capital Management's ten largest holdings make up 26% of its $3.75B portfolio in Q4 2024.
  • Channing Capital Management opened 15 new positions and closed 16 in Q4 2024.
  • Channing Capital Management's portfolio value fell 4.1% quarter-over-quarter to $3.75B.

Based on Channing Capital Management's 13F filing for Q4 2024, filed 7 Feb 2025.